KS

Kevan M. Shokat

Advisory Board at Ikena Oncology

Dr. Shokat currently serves as Professor, Department of Cellular and Molecular Pharmacology at the University of California, San Francisco, and Professor of Chemistry at the University of California, Berkeley. Dr. Shokat is an innovator in the development of chemical methods for investigating cellular signal transduction pathways, with a particular focus on protein kinases and lipid kinases. After receiving his Ph.D. in Organic Chemistry at UC Berkeley with Professor Peter Schultz, and post-doctoral work in immunology at Stanford University with Professor Chris Goodnow, Dr. Shokat began his independent research career at Princeton University. He has been an investigator with the Howard Hughes Medical Institute since 2005.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Ikena Oncology

Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.


Industries

Employees

11-50

Links